Andre Mulder

Dr. Andre Mulder is a medical researcher at the University Medical Center Groningen, University of Groningen, specializing in hematology with particular expertise in myeloid malignancies, mast cell disorders, and coagulation pathologies. His work contributes significantly to UN Sustainable Development Goals related to health and well-being.

His primary research domains include:

• Myeloid malignancies (particularly acute myeloid leukemia - 87% of his work)
• Mastocytosis and hereditary alpha tryptasemia
• Tryptase-related diagnostic methodologies
• Antithrombin deficiencies (36% of his work)
• Stem cell transplantation outcomes
• Clonal hematopoiesis mechanisms

Dr. Mulder's recent publications demonstrate innovative approaches to diagnostic validation using advanced techniques like LC-MS/MS and digital droplet PCR, with significant work on improving transplantation outcomes for older patients with myeloid malignancies. His research shows consistent translational focus from basic science to clinical applications.

He has supervised multiple research projects and contributed to datasets including Factor 11 variants in women with heavy menstrual bleeding. His collaborative network spans multiple institutions with significant co-authorship patterns with researchers like Meijer K., Oude Elberink H.N.G., and Roozendaal C.